About Eywa Pharma
Eywa Pharma is a Healthcare company based in Singapore (Singapore) founded in 2015 by Srinivasan Seshan and Jayakumar Ramamoorthy. Pharmaceutical drugs for multiple therapeutic areas are manufactured. Eywa Pharma has raised $30 million across 1 funding round from investors including Eight Roads Ventures and F-Prime Capital. The company has 24 employees. Its chief executive, as recorded, is Srinivasan Seshan. Its Indian entity Eywa Pharma Private Limited reported revenue of ₹96 Lakh. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.
Company details
Eywa Pharma was established in 2015 in Singapore, where operations center on the pharmaceutical sector. Drugs are produced for various therapeutic areas, supporting healthcare needs across different medical fields. The company maintains its headquarters in Singapore, with activities encompassing drug manufacturing processes tailored to industry standards. No specific services beyond production are detailed in available records.
- Headquarters Singapore, Singapore
- Employees 24
- Founders Srinivasan Seshan, Jayakumar Ramamoorthy
- SectorsHealthcare
- Phone•••• ••••
- Website eywapharma.sg
- Social X
- Legal Name Eywa Pharma Private Limited
- Date of Incorporation 27 Apr, 2015
- Jurisdiction Chengalpattu, Tamil Nadu, India
- Indian entity revenue₹96 Lakh
FY 2025 · -23% YoY
- Indian entity net loss-₹2.89 Cr
FY 2025 · -301% margin
- Indian entity EBITDA-₹1.86 Cr
FY 2025 · -194% margin
- Total Equity Funding$30M (USD)
in 1 rounds
- Latest Funding Round$30M (USD), Series C
Oct 2016
- InvestorsEight Roads Ventures
& 1 more
- Employee Count24
Associated legal entities of Eywa Pharma
Eywa Pharma operates through Eywa Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Eywa Pharma Private Limited CIN U74900TN2015PTC100269 | Active | 27 Apr 2015 | Chengalpattu, Tamil Nadu | ₹1.0 Cr | 24 | 3 | View details |
Funding Insights of Eywa Pharma
Eywa Pharma has successfully raised a total of $30M through 1 strategic funding round. The most recent funding activity was a Series C round of $30 million completed in October 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $30M
- Total Rounds 1
- Last Round Series C — $30M
- First Round $30M
(Oct 2016)
- Investors Count 2
All 1 funding rounds of Eywa Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2016 | $30M | Series C | – | Eight Roads Ventures, F-Prime Capital | – |
2 investors in total: 2 institutional.
Investors in Eywa Pharma
Eywa Pharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Eight Roads Ventures and F-Prime Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investment and global platform support for startups. | 2008 | eightroads.com | London, United Kingdom | |
Investments in life sciences, technology, healthtech, and crypto sectors from global locations. | fprimecapital.com |
Investor details for Eywa Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Eywa Pharma Private Limited (Eywa Pharma)
Eywa Pharma Private Limited is the primary company behind Eywa Pharma. The board of Eywa Pharma Private Limited currently have 2 directors; the longest-serving is Sivakumar Jayaraman, appointed in 2018. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sivakumar Jayaraman DIN 03505493 | Whole-time director | 28 Jul 2018 | 8 yrs 3 mo | Eywa Pharma Private Limited |
| Seshan Srinivasan DIN 00014652 | Director | 30 Apr 2025 | 1 yr 6 mo | Eywa Pharma Private Limited |
People of Eywa Pharma
2 people are tracked at Eywa Pharma (2 in leadership); the tracked headcount is 24.
| Name | Role | Group |
|---|---|---|
| Co-Founder & CEO | Leadership | |
| Co-Founder | Leadership |
Complete people profiles for Eywa Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Eywa Pharma
Figures of Eywa Pharma Private Limited, the primary company behind Eywa Pharma, for FY 2025. Revenue was ₹96 Lakh (-23% year on year). Net loss was -₹2.89 Cr (-301% margin). EBITDA was -₹1.86 Cr (-194% margin). Revenue has grown at a compounded annual rate of -59% over three years and -46% over five years.
- ₹96 LakhRevenue · FY 2025 · -23% YoY
- -₹2.89 CrNet loss · -301% margin
- -₹1.86 CrEBITDA · -194% margin
- ₹29.29 CrPaid-up capital
- 24Employees (provident fund records)
- -59%Revenue CAGR, 3 years
- -46%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Eywa Pharma Private Limited are on its company page.
Detailed financial statements for Eywa Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Eywa Pharma
2 dated milestones of Eywa Pharma across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Eywa Pharma is founded.
- Funding First funding round of $30.0M.
Web traffic of Eywa Pharma
The website of Eywa Pharma (eywapharma.sg) receives about 3K visits a month.
- Monthly visits3K
▲ 14.6% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Eywa Pharma
Complete news archive for Eywa Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eywa Pharma
Eywa Pharma was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Eywa Pharma is headquartered in Singapore, Singapore.
Srinivasan Seshan is the CEO of Eywa Pharma, as recorded in our data. They have also founded this company.
Eywa Pharma is a funded company, having raised a total of $30M across 1 funding round to date. The company's 1st funding round was a Series C of $30M, raised on Oct 2016.
Eywa Pharma has 24 employees.
The primary company behind Eywa Pharma, Eywa Pharma Private Limited, reported revenue of ₹96 Lakh for FY 2025, down 23% year on year.
Eywa Pharma was established in 2015 in Singapore, where operations center on the pharmaceutical sector. Drugs are produced for various therapeutic areas, supporting healthcare needs across different medical fields. The company maintains its headquarters in Singapore, with activities encompassing drug manufacturing processes tailored to industry standards. No specific services beyond production are detailed in available records.
Eywa Pharma has 2 investors. Key investors include Eight Roads Ventures, and F-Prime Capital.
Eywa Pharma operates through Eywa Pharma Private Limited.
The legal entities of Eywa Pharma currently have 2 directors, including Sivakumar Jayaraman, Seshan Srinivasan.